Correction for Pandharkar et al., "Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1".

Pandharkar, Trupti; Zhu, Xiaohua; Mathur, Radhika; Jiang, Jinmai; Schmittgen, Thomas D; Shaha, Chandrima; Werbovetz, Karl A

Pandharkar, Trupti; Zhu, Xiaohua; Mathur, Radhika; Jiang, Jinmai; Schmittgen, Thomas D; Shaha, Chandrima; Werbovetz, Karl A.

Afiliación

Pandharkar T; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Zhu X; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Mathur R; Cell Death and Differentiation Research Laboratory, National Institute of Immunology, New Delhi, India.
Jiang J; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Schmittgen TD; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Shaha C; Cell Death and Differentiation Research Laboratory, National Institute of Immunology, New Delhi, India.
Werbovetz KA; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

Antimicrob Agents Chemother ; 62(1)2018 01.

Article en En | MEDLINE | ID: mdl-29269427

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Antimicrob Agents Chemother Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos